Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles

Journal of Endocrinology

Volumn 152, Issue 2, 1997, Pages 183-192

  Hickey, G J ^a   Jacks, T M ^a   Schleim, K D ^a   Frazier, E ^a   Chen, H Y ^a   Krupa, D ^a   Feeney, W ^a   Nargund, R P ^a   Patchett, A A ^a   Smith, R G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HYDROCORTISONE; IBUTAMOREN; INTERMEDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DOG; DOSE RESPONSE; FEMALE; GROWTH HORMONE RELEASE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031049262     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1520183     Document Type: Article

References (20)

1. Ascacio-Martinez JA & Barrera-Saldana HA 1994 A dog growth hormone cDNA for a mature protein identical to pig growth hormone. Gene 143 277-280.
2. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R & Barkan AL 1994 Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor-1. Journal of Clinical Investigation 94 138-145.
3. Bowers Momamy FA, Reynolds GA & Hong A 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 1537-1545.
4. Cecilia Aguila M & McCann SM 1993 Growth hormone increases somatostatin release and messenger ribonucleic acid levels in the rat hypothalamus. Brain Research 623 89-94.
5. Chastain CB & Ganjam VK 1986 Clinical Endocrinology of Companion Animals, section VIII, pp 552-553. Philadelphia: Lea and Febiger.
6. 2 on growth hormone(GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 124 2791-2798.
7. Cheng K, Chan WW-S, Butler B, Wei L & Smith RG 1993 A novel non-peptidyl growth hormone secretagogue, Hormone Research 40 109-115.
8. Fairhall KM, Mynett A, Smith RG & Robinson ICAF (1995) Consistent GH responses to injections of GH-releasing hexapeptide (GHRP-6) and the non-peptide GH secretagogue, L-692,585. Journal of Endocrinology 145 417-426.
9. Gertz BJ, Barrett JS, Eisenhandler R, Krupa D, Wittreich JM, Siebold JR & Schneider SH 1993 Growth hormone response in man to L-692,429, a novel non-peptide mimic of growth hormone releasing peptide-6. Journal of Clinical Endocrinology and Metabolism 77 1393-1397.
10. Hickey G, Jacks TM, Judith FR, Taylor J, Schoen WR, Krupa D, Cunningham P, Clark J & Smith RG 1994 Efficacy and specificity of L-692,429, a novel non-peptidyl growth hormone secretagogue, in beagles. Endocrinology 134 695-701.
11. Hulse JA, Rosenthal SM, Cuttler L, Kaplan SL & Grumbach MM 1986 The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men. Endocrinology 63 872-878.
12. Jacks T, Hickey G, Judith F, Taylor J, Chen H, Krupa D, Feeney W, Schoen W, Ok D, Fisher M, Wyvratt M & Smith R 1994 Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, Cortisol, prolactin, insulin, and thyroxine levels in beagles. Journal of Endocrinology 143 399-406.
13. Jacks T, Hickey G, Judith F, Schleim K, Frazier E, Krupa D, Hora D Jr, Nargund R, Patchett A & Smith R 1996 MK-0677, a potent novel orally active growth hormone secretagogue - efficacy and specificity in beagles. 78th Annual Meeting of the Endocrine Society, San Francisco, CA. Abstract 601.
14. Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY & Barkan AL 1993 Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Endocrinology 77 1641-1647.
15. Patchett AA, Nargund RP, Tata JR, Chen M-H, Barakat KJ, Johnston DBR, Cheng K, Chan WW-S, Butler B, Hickey G, Jacks T, Schleim K, Pong S-S, Chaung L-YP, Chen HY, Frazier E, Leung KH, Chiu S-HL & Smith RG 1995 Design and biological activities of L-163,191 (MK-0677): a potent orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the USA 92 7001-7005.
16. Pong S-S, Chaung L-YP, Dean D, Nargund RP, Patchett AA & Smith RG 1996 Identification of a new G-protein linked receptor for growth hormone secretagogues. Molecular Endocrinology 10 57-61.
17. Schleim K-D, Jacks T, Cunningham P, Feeney W, Frazier EG, Niebauer GW, Zhang D, Chen H, Smith RG & Hickey G 1996 Effect of MK-677 on growth hormone and Cortisol in beagles before and after hypophysectomy. 78th Annual Meeting of the Endocrine Society, San Francisco, CA. Abstract 603.
18. Smith RG, Cheng K, Schoen W, Pong S, Hickey G, Jacks T, Butler B, Chan W, Chaung L, Judith F, Taylor J, Wyvratt M & Fisher M 1993 A non-peptidyl growth hormone secretagogue. Science 260 1640-1643.
19. Smith RG, Pong S-S, Hickey G, Jacks T, Cheng K, Leonard R, Cohen C, Arena JP, Chang CH, Drisko J, Wyvratt M, Fisher M, Nargund R & Patchett A 1996 Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Progress in Hormone Research 51 261-286.
20. Sugihara H, Minami S, Okada K, Kamegai J, Hsagawa O & Wakabayashi I 1993 Somatostatin reduces transcription of the growth hormone gene in rats. Endocrinology 132 1225-1229.